WuXi Biologics Tops Out Key Drug Product Facility at Singapore Hub
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has completed the topping out of the Drug Product (DP) facility at its Singapore CRDMO Hub (Hub). Once operational, the facility will be the Company's key DP facility designed to meet the latest an…
